Entrada Therapeutics (TRDA) Earnings Date, Estimates & Call Transcripts $5.65 -0.03 (-0.53%) Closing price 04:00 PM EasternExtended Trading$5.65 0.00 (0.00%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Entrada Therapeutics Earnings Summary Entrada Therapeutics issued Q2 2025 earnings on August 6, 2025, reporting an EPS of -$1.04, which missed the consensus estimate of -$0.86 by $0.18. Quarterly revenue was reported to be $1.98 million, below analysts' expectations of $8.17 million. With a trailing EPS of -$1.78, Entrada Therapeutics' earnings are expected to decrease next year, from $1.12 to ($3.23) per share. Upcoming Q3 Earnings DateNov. 4Before Market OpensEstimatedConsensus EPS (Aug. 6) -$0.86 Actual EPS (Aug. 6) -$1.04 Missed By -$0.18 Actual Revenue (Aug. 6) $1.98MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K) Slide DeckSEC FilingTRDA Upcoming EarningsEntrada Therapeutics' next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Entrada Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Entrada Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataTRDA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TRDA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Entrada Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.92-$0.72-$0.82Q2 20253-$0.98-$0.75-$0.87Q3 20253-$1.13-$0.88-$1.04Q4 20253-$1.26-$0.78-$1.08 FY 2025 11 -$4.29 -$3.13 -$3.81 Q1 20263-$1.32-$0.80-$1.11Q2 20263-$1.38-$0.83-$1.14Q3 20263-$1.45-$0.88-$1.16Q4 20263-$1.51-$0.93-$1.17 Entrada Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/4/2025(Estimated)--------8/6/2025Q2 2025-$0.86-$1.04 -$0.18-$1.04$8.17M$1.98M5/8/2025Q1 2025-$0.78-$0.42+$0.36-$0.42$10.98M$8.75M2/27/2025Q4 2024-$0.66$0.03+$0.69$0.03$11.95M$12.25M8/13/2024-$0.65$1.55+$0.90$1.55$55.00M$94.69M5/7/2024Q1 2024-$0.38$0.68+$1.06$0.68$25.00M$59.12M3/13/2024Q4 2023-$0.07-$0.29 -$0.22-$0.29$27.82M$41.85M11/7/2023Q3 2023-$0.55$1.02+$1.57$1.02$16.31M$43.74M Entrada Therapeutics Earnings - Frequently Asked Questions When is Entrada Therapeutics' earnings date? Entrada Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 4th, 2025 based off last year's report dates. Learn more on TRDA's earnings history. Did Entrada Therapeutics beat their earnings estimates last quarter? In the previous quarter, Entrada Therapeutics (NASDAQ:TRDA) missed the analysts' consensus estimate of ($0.86) by $0.18 with a reported earnings per share (EPS) of ($1.04). Learn more on analysts' earnings estimate vs. TRDA's actual earnings. How can I view Entrada Therapeutics' earnings report? Entrada Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Entrada Therapeutics generate each year? Entrada Therapeutics (NASDAQ:TRDA) has a recorded annual revenue of $210.78 million. How much profit does Entrada Therapeutics generate each year? Entrada Therapeutics (NASDAQ:TRDA) has a recorded net income of $65.63 million. TRDA has generated -$1.78 earnings per share over the last four quarters. What is Entrada Therapeutics' EPS forecast for next year? Entrada Therapeutics' earnings are expected to decrease from $1.12 per share to ($3.23) per share in the next year. More Earnings Resources from MarketBeat Related Companies Niagen Bioscience Earnings Date Pharming Group Earnings Date ArriVent BioPharma Earnings Date Sana Biotechnology Earnings Date Gyre Therapeutics Earnings Date Oculis Earnings Date Ginkgo Bioworks Earnings Date atai Life Sciences Earnings Date Immatics Earnings Date Tango Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NASDAQ:TRDA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entrada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access